Australia
· Delayed Price · Currency is AUD Avecho Biotechnology Company Description
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.
It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery.
Its human health portfolio covers delivery of pharmaceutical products for pain and dermatology applications through gels, injectables, and patches.
In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals.
The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019.
Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
| Country | Australia |
| Founded | 1992 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Paul Gavin |
Contact Details
Address: Hallmarc Business Park Clayton, 3168 Australia | |
| Phone | 61 3 9002 5000 |
| Website | avecho.com.au |
Stock Details
| Ticker Symbol | AVE |
| Exchange | Australian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | AUD |
| ISIN Number | AU0000047441 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Paul Gavin BSc (Hons), Ph.D. | Chief Executive Officer |
| Dr. Roksan Libinaki Ph.D. | Chief Operating Officer |
| Melanie Jaye Leydin B.Bus, C.A., CA | Company Secretary |